Integrating hepatitis prevention services into a substance use disorder clinic

Journal of Substance Abuse Treatment

Volumn 32, Issue 4, 2007, Pages 391-398

  Hagedorn, Hildi ^a,b   Dieperink, Eric ^a,b,c   Dingmann, Debra ^a   Durfee, Janet ^a,b,c   Ho, Samuel B ^a,b,c   Isenhart, Carl ^a,b   Rettmann, Nancy ^a   Willenbring, Mark ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Hepatitis C Resource Center   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Hepatitis C infections; Hepatitis services; Implementation; Substance abuse treatment programs; Vaccinations

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ARTICLE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH SERVICE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HUMAN; INFECTION CONTROL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; VACCINATION;

FEMALE; FOLLOW-UP STUDIES; HEPATITIS A; HEPATITIS B; HEPATITIS C; HOSPITALS, VETERANS; HUMANS; IMMUNIZATION PROGRAMS; MALE; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED; MINNESOTA; PATIENT EDUCATION; PILOT PROJECTS; PREVENTIVE HEALTH SERVICES; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 34247515936     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.10.004     Document Type: Article

References (28)

1. Abraham H.D., Degli-Esposti S., and Marino L. Seroprevalence of hepatitis C in a sample of middle class substance abusers. Journal of Addictive Diseases 18 (1999) 77-87
2. Almasio P.L., and Amoroso P. HAV infection in chronic liver disease: A rationale for vaccination. Vaccine 21 (2003) 2238-2241
3. Astone J., Strauss S.M., Vassilev Z.P., and Des Jarlais D.C. Provision of hepatitis C education in a nationwide sample of drug treatment programs. Journal of Drug Education 33 (2003) 107-117
4. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic liver disease. Morbidity and Mortality Weekly Report 47 (1998) 1-39
5. Centers for Disease Control and Prevention. Hepatitis A and hepatitis B. Epidemiology and prevention of vaccine-preventable diseases. 7th ed. (2002) 156-186
6. Chitwood D.D., McBride D.C., French M.T., and Comerford M. Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use and Misuse 34 (1999) 727-746
7. Contoreggi C., Rexroad V.E., and Lange W.R. Current management of infectious complications in the injecting drug user. Journal of Substance Abuse Treatment 15 (1998) 95-106
8. Dhopesh V.P., and Taylor K.R. Survey of hepatitis B and C in addiction treatment unit. American Journal of Drug and Alcohol Abuse 26 (2000) 703-707
9. El-Serag H.B., Kunik M., Richardson P., and Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 123 (2002) 476-482
10. Fingerhood M.I., Jasinski D.R., and Sullivan J.T. Prevalence of hepatitis C in a chemically dependent population. Archives of Internal Medicine 153 (1993) 2025-2030
11. Heintges T., and Wands J.R. Hepatitis C virus: Epidemiology and transmission. Hepatology 26 (1997) 521-526
12. Keeffe E.G. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?. American Journal of Gastroenterology 90 (1995) 201-205
13. Keeffe E.B. Vaccination against hepatitis A and B in chronic liver disease. Viral Hepatitis Review 5 (1999) 77-88
14. Kelen G.D., Green G.B., Purcell R.H., Chan D.W., Qaqish B.F., Sivertson K.T., et al. Hepatitis B and hepatitis C in emergency department patients. New England Journal of Medicine 326 (1992) 1399-1404
15. Koff R.S. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. Journal of Clinical Gastroenterology 33 (2001) 20-26
16. Mendenhall C.L., Moritz T., Rouster S., Rossele G., Polito A., Quan S., et al. Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275. American Journal of Gastroenterology 88 (1993) 1022-1026
17. Nguyen H.A., Miller A.I., Dieperink E., Willenbring M.L., Tetrick L.L., Durfee J.M., et al. Spectrum of disease in U.S. veteran patients with hepatitis C. American Journal of Gastroenterology 97 (2002) 1813-1820
18. Rifai M.A., Moles J.K., Lehman L.P., and Van der Linden B.J. Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Psychosomatics 47 (2006) 112-121
19. Reiss G., and Keeffe E.B. Review article: Hepatitis vaccination in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics 19 (2004) 715-727
20. Rosman A.S., Waraich A., Galvin K., Casiano J., Paronetto F., and Lieber C.S. Alcoholism associated with hepatitis C but not hepatitis B in an urban population. American Journal of Gastroenterology 91 (1996) 498-505
21. Shim M., Khaykis I., Park J., and Bini E.J. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination. Hepatology 42 (2005) 688-695
22. Simonetti R.G., Camma C., and Fiorello F. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case-control study. Annals of Internal Medicine 116 (1992) 97-102
23. Sorensen J.L., Masson C.L., and Perlman D.C. HIV/Hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives (2002) 4-12
24. Strauss S.M., Astone J.M., Hagan H., and Des Jarlais D.C. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. Journal of Urban Health 18 (2004) 38-47
25. Strauss S.M., Falkin G.P., Vassilev Z., Des Jarlais D.C., and Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment 22 (2002) 55-62
26. Tortu S., Neaigus A., McMahon J., and Hagen D. Hepatitis C among noninjecting drug users: A report. Substance Use and Misuse 36 (2001) 523-534
27. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., et al. Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. New England Journal of Medicine 338 (1998) 286-290
28. Yu M.D., Tong M.J., and Corsaget P. Prevalence of hepatitis B and C viral markers in Black and White patients with hepatocellular carcinoma in the United States. Journal of the National Cancer Institute 82 (1990) 1038-1041